O

Ondine Biomedical Inc
LSE:OBI

Watchlist Manager
Ondine Biomedical Inc
LSE:OBI
Watchlist
Price: 8.75 GBX 1.74% Market Closed
Market Cap: 45.4m GBX
Section:
 

Relative Value

OBI latest financial reports are more than 11 years old.

The Relative Value of one OBI stock under the Base Case scenario is hidden GBX. Compared to the current market price of 8.75 GBX, Ondine Biomedical Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

OBI Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

38
P/S
P/S
Price to Sales
38
vs History
94
vs Industry
4
Median 3Y
63.6
Median 5Y
73.5
Industry
2.3
Forward
0.2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-5.3
Median 5Y
-5.7
Industry
22.6
Forward
-0
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-6.4
Median 5Y
-6.8
Industry
14.3
More Details
16.5
P/FCFE
P/FCFE
Price to FCFE
16.5
vs History
12
vs Industry
Median 3Y
-6.7
Median 5Y
-8.1
Industry
21.6
More Details
115.3
P/B
P/B
Price to Book Value
115.3
vs History
24
vs Industry
100
Median 3Y
26.3
Median 5Y
18
Industry
2.2
More Details
Negative
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
Median 3Y
-301.2
Median 5Y
-377.9
Industry
2.5
Forward
-0.9
More Details
Negative
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
-614.6
Median 5Y
-676
Industry
5.1
More Details
19
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
19
vs History
48
vs Industry
51
Median 3Y
16.6
Median 5Y
18.5
Industry
11.9
Forward
0.1
More Details
18.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
18.6
vs History
48
vs Industry
49
Median 3Y
16.2
Median 5Y
18.1
Industry
16.8
Forward
0.1
More Details
24.1
EV/OCF
EV/OCF
Enterprise Value to OCF
24.1
vs History
48
vs Industry
51
Median 3Y
21
Median 5Y
23.5
Industry
14.6
More Details
24.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
24.1
vs History
48
vs Industry
42
Median 3Y
21
Median 5Y
23.4
Industry
18.6
More Details
Negative
EV/IC
EV/IC
Enterprise Value to IC
N/A
vs History
vs Industry
Median 3Y
-217.1
Median 5Y
-242.2
Industry
1.8
More Details

Multiples Across Competitors

OBI Competitors Multiples
Ondine Biomedical Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Ondine Biomedical Inc
LSE:OBI
45.4m GBP 38 -3.5 19 18.6
US
Abbott Laboratories
NYSE:ABT
217.1B USD 5 15.5 19.8 27.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
207.1B USD 21.5 75.4 57.8 70.6
US
Boston Scientific Corp
NYSE:BSX
142.4B USD 7.4 51 29.8 40.6
US
Stryker Corp
NYSE:SYK
135.4B USD 5.6 46 22.5 27.2
IE
Medtronic PLC
NYSE:MDT
123.7B USD 3.6 26 14.7 21.2
DE
Siemens Healthineers AG
XETRA:SHL
49.9B EUR 2.1 23.3 13.2 18.6
US
Becton Dickinson and Co
NYSE:BDX
56B USD 2.6 33.4 12.4 21
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.1B USD 13.2 53.6 38.5 42.6
US
Edwards Lifesciences Corp
NYSE:EW
50.4B USD 8.6 36.9 26.4 28.9
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.1B USD 1.9 17.2 12.8 15.5

See Also

Summary
OBI intrinsic value, competitors valuation, and company profile.
DCF Valuation
OBI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
OBI stock valuation using valuation multiples.
Wall Street Estimates
OBI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
OBI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 305,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.